2020
DOI: 10.1186/s13063-020-04649-9
|View full text |Cite
|
Sign up to set email alerts
|

The effect of on-site CT-derived fractional flow reserve on the management of decision making for patients with stable chest pain (TARGET trial): objective, rationale, and design

Abstract: Background: The diagnostic accuracy of CT-derived fractional flow reserve (CT-FFR) in clinical application has been well validated. This advanced technology focus on evaluating anatomical stenosis and functional ischemia simultaneously. However, the effect of CT-FFR on the management of decision making has not been fully evaluated in randomized controlled design. Method/design: TARGET study is a pragmatic, multicenter, prospective, open-label, and randomized controlled trial evaluating the effect of a CCTA/CT-… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

4
2

Authors

Journals

citations
Cited by 8 publications
(11 citation statements)
references
References 15 publications
0
11
0
Order By: Relevance
“…The evaluation criteria of stress test examinations are available in the trial protocol. 13 Patients with positive stress tests were recommended to undergo ICA and subsequent coronary revascularization if indicated.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The evaluation criteria of stress test examinations are available in the trial protocol. 13 Patients with positive stress tests were recommended to undergo ICA and subsequent coronary revascularization if indicated.…”
Section: Methodsmentioning
confidence: 99%
“…The trial design and methods have been published previously. 13 The study protocol and other relevant documentation were approved by the institutional human research ethics committee of Chinese People's Liberation Army General Hospital and the relevant national ethics committees and registered on https:// www.clinicaltrials.gov (Unique identifier: NCT03901326). The trial steering committee monitored the progress of all aspects of the trial.…”
Section: Trial Design and Oversightmentioning
confidence: 99%
“…Combined with the functional assessment of CT-FFR, it can identify physiologically significant flow-limiting lesions and identify target vessels. The TARGET study 27 will provide evidence for the clinical application of CT-FFR. In contrast, based on imaging, intraluminal imaging examinations, IVUS and OCT are the gold standards for identifying plaque tissue components, especially for complex lesions such as the LM, bifurcation lesions, and CTO.…”
Section: Discussionmentioning
confidence: 99%
“…A retrospective analysis by Qiao et al25showed that CT-FFR could guide diagnosis and treatment decisions, improve the efficiency of invasive coronary angiography (ICA) treatment, and reduce the number of ICA referrals by 54.5% and PCI by 4.4%. As an alternative to ICA, its safety and feasibility in selecting patients requiring PCI were confirmed in the study of Liu et al26 The impact of CT-FFR-guided management on the clinical outcome was being prospectively investigated in a multisite clinical study across China 27. In addition, CT-FFR can also assess ISR,28 showing prognostic value in predicting MACE after stent implantation in low, moderate risk patients (bias-corrected c-index: 0.846).…”
Section: Imaging In Coronary Interventionmentioning
confidence: 95%
See 1 more Smart Citation